ArticleJACC. Cardiovascular imaging2025
Machine Learning Identification of Patient Phenoclusters in Aortic Regurgitation.
Article in JACC. Cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Emerging Role of Artificial Intelligence in the Assessment of Valvular Heart Disease with Cardiac Imaging.Current cardiology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundCurrent treatment paradigms assume aortic regurgitation (AR) patients to be a homogenous population, but varied courses of disease progression and outcomes are observed clinically.
objectivesThe aim of this study was to first use unsupervised machine learning to identify unique patient phenoclusters in AR, and subsequently evaluate their prognostic relevance.
methodsClinical and cardiac magnetic resonance (CMR) characterization of moderate or severe AR patients was performed across 4 U.S. CENTERS: Data from 2 centers were used for derivation of phenoclusters and validation was performed in the other 2. The outcome was all-cause death. An unsupervised clustering pipeline, Partition Around Medoids, used 23 clinical and CMR variables to derive patient clusters independent of outcomes.
resultsIncluded were 972 patients with mean age 62 ± 23.2 years, 754 (78%) male, 680 (70%) trileaflet valve, and 330 (34%) underwent valve surgery. Over a median follow-up of 2.58 years (Q1-Q3: 1.03-5.50 years), the overall mortality rate was 12%. Four clusters were derived: 1) a younger predominantly male phenotype with majority of bicuspid aortic valve and high extent of left ventricular (LV) remodeling (1% mortality); 2) older male patients with predominantly tricuspid valves and intermediate outcomes (10% mortality); 3) older predominantly male patients with the highest burden of comorbidities, LV scarring, and dysfunction (22% mortality); and 4) a phenotype of predominantly female patients with high mortality and relatively higher symptoms burden, relatively lower extent of LV remodeling, and rate of aortic valve replacement (20% mortality). The clustering algorithm was independently associated with survival after adjustment for time-dependent aortic valve replacement and traditional risk markers of prognosis in patients with AR (C statistic 0.77 vs 0.75; P = 0.009 in the validation cohort).
conclusionsUnique patient phenoclusters of AR are described using a machine learning approach leveraging comprehensive CMR and clinical characterization. This approach may be an opportunity for a precision medicine approach to enhance risk stratification of patients with AR. Female patients with AR pose a unique phenotype with high mortality, which deserves greater attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.